Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phlebotomy before peginterferon alfa-2a/ribavirin in treatment-naive hepatitis C genotype 1 patients with elevated ferritin
ISRCTN11801541Phase 4Completed
- Sponsor
- Universitätsklinikum Düsseldorf
- Start
- Apr 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of peginterferon alfa-2a and ribavirin, sponsored by Universitätsklinikum Düsseldorf. Started Apr 2006; status: completed.
02
Drugs
peginterferon alfa-2aribavirin
Beyond the preview
Go deeper on ISRCTN11801541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11801541.